Profile photo Angelika Mühlebner

Angelika Mühlebner

Associate Professor - medical

Strategic program(s):

Biography

Medical University Vienna, Vienna, Austria

MD

31-07-2008

medicine

Medical University Vienna, Vienna, Austria

 

31-08-2009

neuropathology residency

University Hospital Erlangen, Erlangen, Germany

PhD

12-05-2012

epilepsy-associated pathology

Medical University Vienna, Vienna, Austria

 

31-03-2014

pediatrics residency

Amsterdam Medical Center, AMC, Amsterdam, The Netherlands

 

31-12-2015

postdoctoral researcher

Amsterdam Medical Center, AMS, Amsterdam, The Netherlands

 

30-09-2020

pathology residency

University Medical Center Utrecht, Utrecht, The Netherlands

Associate professor

21-12-2021

fellowship neuropathology

University Medical Center Utrecht, Utrecht, The Netherlands

 

ongoing

neuropathology, head of cytology unit

Research groups

Neuropathology

Research aim

Our aim is to drive and improve state-of-the-art diagnostics, enhance knowlegde and advance targeted interventions for individuals affected by neurological disorders.

Go to group

Recent publications

Impaired GABAergic regulation and developmental immaturity in interneurons derived from the medial ganglionic eminence in the tuberous sclerosis complex Mirte Scheper, Frederik N F Sørensen, Gabriele Ruffolo, Alessandro Gaeta, Lilian J Lissner, Jasper J Anink, Irina Korshunova, Floor E Jansen, Kate Riney, Wim van Hecke, Angelika Mühlebner, Konstantin Khodosevich, Dirk Schubert, Eleonora Palma, James D Mills, Eleonora Aronica
Acta Neuropathologica, 2024, vol. 147
T2-FLAIR Mismatch: An Imaging Biomarker for Children's MYB/MYBL1-Altered Diffuse Astrocytoma or Angiocentric Glioma. E A van Maren, J W Dankbaar, P Wesseling, S Plasschaert, A Muhlebner, E W Hoving, P A Robe, T J Snijders, R Hoogendijk, M E G Kranendonk, M H Lequin
AJNR. American journal of neuroradiology, 2024, vol. 45, p.747-752
Diffuse, IDH-wildtype gliomas in adults with minimal histological change and isolated TERT promoter mutation L P Priesterbach-Ackley, F Cordier, P de Witt Hamer, T J Snijders, P A Robe, B Küsters, W W J de Leng, W F A den Dunnen, D Brandsma, C Jansen, P Wesseling, A Muhlebner
Acta Neuropathologica, 2024, vol. 148
Clinical characteristics and survival outcomes of patients with primary central nervous system lymphoma treated with high-dose methotrexate-based polychemotherapy and consolidation therapies Fleur A de Groot, Tim J A Dekker, Jeanette K Doorduijn, Stefan Böhringer, Mirian Brink, Ruben A L de Groen, Lorraine M de Haan, F J Sherida H Woei-A-Jin, Troy Noordenbos, Aniko Sijs-Szabo, Mirjam A Oudshoorn, King H Lam, Arjan Diepstra, Liane C J Te Boome, Valeska Terpstra, Lara H Bohmer, Alina Nicolae, Eduardus F M Posthuma, Lianne Koens, Marc F Durian, Jeroen Stavast, Marjolein W M van der Poel, Myrurgia Abdul Hamid, Wendy B C Stevens, Sjo L M van Rooij, Rimke S Oostvogels, Angelika Mühlebner, Karen J Neelis, Michiel van den Brand, Thomas Tousseyn, Daan Dierickx, Okke de Weerdt, Aart Beeker, Patty M Jansen, Marie José Kersten, Josée M Zijlstra, Martine E D Chamuleau, Hendrik Veelken, Jacoline C E Bromberg, Marcel Nijland, Joost S P Vermaat
European Journal of Cancer, 2024, vol. 213